Haplotypes of DNA repair and cell cycle control genes, X-ray exposure, and risk of childhood acute lymphoblastic leukemia
2011 · Cancer Causes & Control · 27 citations
https://doi.org/10.1007/s10552-011-9848-y
K
Karen Bartley
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
41
Papers
568
Citations
11
h-index
14
i10-index
Karen Bartley is an academic researcher from Pfizer (United States). The author has contributed to research in topics: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis & Advanced Breast Cancer Therapies & Acute Lymphoblastic Leukemia research. The author has an h-index of 11, co-authored 35 publications.
Papers by this author
worksAssessment of quality of life using Skindex-16 in patients with advanced basal cell carcinoma treated with vismodegib in the STEVIE study
2018 · European Journal of Dermatology · 25 citations
https://doi.org/10.1684/ejd.2018.3448
Patient journey and treatment patterns in adults with IPF based on health care data in Sweden from 2001 to 2015
2019 · Respiratory Medicine · 24 citations
https://doi.org/10.1016/j.rmed.2019.06.001
Epidemiology of Pulmonary Fibrosis: A Cohort Study Using Healthcare Data in Sweden
2019 · Pulmonary Therapy · 16 citations
https://doi.org/10.1007/s41030-019-0087-9
Healthcare Resource Utilization and Cost of Care in Patients With Periocular Basal Cell Carcinoma: A Real-World Study
2021 · American Journal of Ophthalmology · 8 citations
https://doi.org/10.1016/j.ajo.2021.10.015
Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry
2022 · Pulmonary Therapy · 8 citations
https://doi.org/10.1007/s41030-022-00187-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat